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The bacterial Type 6 secretion system (T6SS) translo-
cates protein toxins (also called effectors) from the
cytosol of a T6SS-carrying cell to a target cell by a
syringe-like supramolecular complex resembling a con-
tractile tail of bacteriophages. Valine-glycine repeat
protein G (VgrG) proteins, which are the homologues
of the gp27-gp5 (gene product) cell puncturing complex
of bacteriophage T4, are considered to be located at the
attacking tip of the bacterial T6SS apparatus. Here,
we over-expressed six VgrG proteins from pathogenic
Escherichia coli O157 and CFT073 strains. Puriﬁed
VgrG1 of E. coli O157 and c3393 of E. coli CFT073
form trimer in solution and are rich in b-structure. We
also solved the crystal structure of a trypsin-resistant
C-terminal fragment of E. coli O157 VgrG1
(VgrG1CG561) at 1.95 A˚ resolution. VgrG1CG561
forms a three-stranded antiparallel b-helix which is
structurally similar to the b-helix domain of the central
spike protein (gp138) of phi92 phage, indicating a pos-
sible evolutional relationship. Comparison of four dif-
ferent three-stranded b-helix proteins shows how their
amino acid composition determines the protein fold.
Keywords: bacteria/structure/three-stranded b-helix/
Type 6 secretion system/X-ray crystallography.
Abbreviations: CD, circular dichroism; CHES,
N-Cyclohexyl-2-aminoethanesulphonic acid; c(s),
sedimentation coefﬁcient distribution function; gp,
gene product; LB, Luria-Bertani; OB fold, oligo-
nucleotide-/oligosaccharide-binding fold; PAAR
motif, proline-alanine-alanine-arginine motif; RHS,
rearrangement hot spot; SeMet, seleno methionine;
T6SS, Type 6 secretion system; TEV, tobacco etch
virus; VgrG, valine-glycine repeat protein G.
Bacterial Type 6 secretion system (T6SS) is one of the
largest organelles localized in the cell membrane (1).
The related genes of the secretion system form a clus-
ter. Most genes encoding T6SS proteins often cluster
together, and this cluster consists of highly conserved
13 core genes and several strain-speciﬁc genes (2). The
structural proteins of T6SS assemble into a contractile
supramolecular structure with the length of 0.7mm
(1). Upon contraction of the sheath structure, it short-
ens down to 0.4 mm and drives secretion of protein
toxins or effector molecules into target cells (1). T6SS
plays various physiological functions, e.g. cytotoxicity
against eukaryotic cells by actin crosslinking [Vibrio
cholerae (3, 4)] or actin ribosylation [Aeromonas hydro-
phila (5)], interbacterial competition [Pseudomonas aer-
uginosa (6, 7) and V. cholerae (8)], bioﬁlm formation
[enteroaggregative Escherichia coli (9)] and virulence
[Burkholderia mallei (10, 11) and P. aeruginosa
(12, 13)].
The Type 6 secretion apparatus consists of two
parts, namely a syringe-like structure extending to
the cell membrane and the membrane-associated pro-
tein complex. Recent studies indicated that the syringe-
like structure is structurally analogous to the tail of
contractile bacteriophage though it is much longer
than the contractile tail (the tail of T4 phage is
0.1 mm). The syringe-like structure is assumed to con-
tain (among others) the following proteins—VgrG,
Hcp and VipA/VipB—which are the homologues of
the gp27gp5 (gene product) complex, gp19 (tail tube
protein) and gp18 (tail sheath protein) of T4 phage,
respectively (1). On the other hand, most of the mem-
brane-associated proteins are not homologous to
phage proteins. Interestingly, a homologue of a small
protein from the T4 tail baseplate called gp25, is found
in T6SS. Therefore, membrane-associated proteins
may function as the baseplate of T6SS (14).
T4 phage is a very well-characterized bacteriophage
that infects E. coli (15). It injects its genomic DNA into
the host cell by a contractile tail which is constituted of
a co-cylinder structure and the baseplate at the distal
end. The co-cylinder structure consists of two parts
namely, tail tube (passage of DNA, gp19) and con-
tractile tail sheath (gp18) surrounding the tube. The
tip of the tail tube carries a needle- or spike-shaped
structure called the gp27gp5 tail lysozyme complex
(16). Upon infection, the gp27gp5 complex penetrates
the outer membrane of the host cell and locally
degrades the peptidoglycan layer with the help of the
lysozyme domain that is part of gp5 (16). The
C-terminal domain of T4 gp5 contains a tandem 8
amino acid repeat of (VXGXXXXX), which forms a
three-stranded b-helix in gp5 trimer (16). It is a highly
stable structure and shows resistance to 10% sodium
dodecyl sulfate (SDS) and 2M guanidine HCl (16).
The three-stranded b-helix is conserved in the central
J. Biochem. 2014;155(3):173–182 doi:10.1093/jb/mvt109
 The Authors 2013. Published by Oxford University Press on behalf of the Japanese Biochemical Society. All rights reserved 173
spike proteins ofMyoviridae such as phi92, P2 and Mu
phages, though there are two types of three-stranded b-
helix; one is made of fully intertwined b-helix and the
other is made of three antiparallel b-sheets (1719).
In T6SS, valine-glycine repeat protein G
(VgrG) protein is thought to function similar to the
gp27gp5 complex in T4 tail. VgrG is an essential
component of T6SS and found in the culture super-
natants of the T6SS expressing cells (3, 8, 20).
Multiple vgrG genes are often found in many bacterial
genomes. They often contain a conserved part, which
corresponds to genes 27 and 5 of T4 fused together,
and a variable 30 part, which encodes various enzym-
atic domains called ‘effectors’ (e.g. actin-crosslinking
domain and peptidoglycan-binding domain found in
V. cholerae V52) (3). Interestingly, VgrG protein is
predicted to contain triple-stranded b-helix as in gp5
of T4 phage (3), but the number of predicted b-strands
and their amino acid sequences are highly diverse in
VgrG proteins. Some VgrGs display a VXGXXXXX
repeat (X, any amino acid), which characterizes the T4
gp5 b-helix with others displaying a VGXXXXXX
repeat and yet others showing another repeat or no
apparent repeat at all. How these sequence variations
are reﬂected in the three dimensional structure is of
great interest.
In this study, we characterize six VgrG proteins
from E. coli O157 and CFT073 strains and show that
both E. coli VgrG1 and E. coli CFT073 c3393 are
trimer in solution and rich in b-structure as in T4
gp27gp5 complex, except for the lysozyme domain
which is absent in these VgrG proteins. We also
solved the crystal structure of the C-terminal fragment
of E. coli O157 VgrG1 and proved that it forms a
three-stranded b-helix. It resembles the antiparallel
b-helix domain of the central spike proteins from
phi92 phage (17). Finally, we propose a method for
prediction of b-helix topology and show that it is pos-
sible to predict the structure and topology of several
diverse VgrG proteins to some extent.
Materials and Methods
Chemicals
All the chemicals were purchased from Nacalai Tesque (Japan) or
Wako Pure Chemical Industries (Japan). Protein markers were
purchased from Bio-Rad Laboratories.
Plasmid construction
The vgrG genes, vgrG1 (locus tag Z0707), vgrG2 (locus tag Z2262),
vgrG3 (locus tag Z0267) of E. coli O157 EDL933 and c3393, c1888,
c1883 of E. coli CFT073 were polymerase chain reaction (PCR)-
ampliﬁed from genome DNA of each E. coli using the primers
listed in Supplementary Table S1. The over-expression vectors of
each full-length VgrG protein were constructed by inserting vgrG
gene into pET29a vector using the restriction enzyme sites of NdeI
and XhoI. The resulting plasmids express VgrG protein with
C-terminal hexahistidine tag. The expression vector of the b-helix
domain of VgrG1 (residues 467633) with C-terminal hexahisti-
dine ag was constructed in the same way but using the primer
pairs of VgrG1-Nde1-467M(þ) and Ec933Vgr1-Gly-Xho()
(Supplementary Table S1 for details). The expression vectors of
the b-helix domain of E. coli O157 VgrG2 and VgrG3 with N-ter-
minal SlyD protein were constructed as follows. The VgrG2 residues
474714 and VgrG3 residues 458713 were ampliﬁed by PCR using
the primers of VgrG2-BamHI-G474(þ) and Ec933Vgr2-STP-
Xho() or VgrG3-BamHI-G458 (þ) and Ec933Vgr3-STP-Xho()
(Supplementary Table S1) and inserted to pSL vector by BamHI
and XhoI restriction enzyme sites. pSL vector was made from
pESL (21) by deleting a linker sequence between tobacco etch
virus (TEV) protease site and multiple cloning site. The resulting
plasmids express the b-helix domain of VgrG2 and VgrG3 with
cleavable hexahistidine tag and SlyD at N-terminus. The C-terminal
fragment of VgrG proteins are named as VgrGC with the starting
residue in upper right (e.g. VgrG2CG474). The N-terminal and C-
terminal hexahistidine tag are indicated with his in upper left and
upper right, respectively (e.g. VgrG2his). A schematic view of the
constructs used in this study is shown in Supplementary Fig. S4.
All the nucleotide sequence of vgrG gene in the expression vector
was conﬁrmed by DNA sequencing.
Protein expression
The expression of E. coli O157 VgrG1his, VgrG2his, VgrG3his,
VgrG1CM467-his, hisSlyD-VgrG2CG474 and hisSlyD-VgrG3CG458 was
performed as follows. BL21(DE3) was transformed by the expres-
sion vector described above and cultivated at 37C in Luria-Bertani
(LB) medium supplemented with 60 mg/ml kanamycin. For the
expression of VgrG1his, VgrG2his and VgrG3his, isopropyl-b-D-
thiogalactopyranoside (IPTG) was added to the ﬁnal concentration
of 0.1mM when OD660 was 0.40.5 and further cultivated at 25
C
for 6 h. For the expression of VgrG1CM467-his, IPTG was added at a
ﬁnal concentration of 1mM and cultivated at 20C for 5 h. The
SeMet derivative of VgrG1CM467-his was expressed basically in the
same way as native protein but E. coli B384(DE3) and Le Master
medium (22) supplemented with 25mg/l Seleno-L-Methionine
were used. For the expression of hisSlyD-VgrG2CG474 and hisSlyD-
VgrG3CG458, IPTG was added to 1mM ﬁnal concentration and
further cultivated at 20C for 10 h.
c3393his, c1888his and c1883his from E. coli CFT073 were
expressed as follows. E. coli KRX (Promega Corporation, USA)
was transformed by the expression plasmid and cultivated at 37C
in LB medium containing 60 mg/ml kanamycin. The expression was
induced by 0.1% rhamnose and 1mM IPTG when OD660 was about
0.5 and incubated at 16C for 18 h. All cells were harvested by cen-
trifugation at 2,500g for 10min using Himac CR22G centrifuge
with R9AF rotor (Hitachi Koki).
The soluble content of VgrG1his and c3393his were estimated by
ImageJ (23) using scanned sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDSPAGE) gels by CanoScan D1250U2
(Canon Inc.).
Protein purification
VgrG1his, c3393his, VgrG1CM467-his, hisSlyD-VgrG2CG474 and
hisSlyD-VgrG3CG458 which have hexahistidine tag were puriﬁed as
follows. The cell was suspended in 10 volume of buffer A (50mM
Tris pH8.0, 100mM NaCl, 20mM imidazole) and lysed by sonic-
ation in the presence of 1mM phenylmethylsulphonyl ﬂuoride. The
cell lysate was centrifuged at 20,000g (R18A rotor with Himac
CR22G centrifuge, Hitachi Koki) for 20min and supernatant was
loaded to HisTrap FF column (GE Healthcare) which was equili-
brated with buffer A. VgrG1his, c3393his, VgrG1CM467-his, hisSlyD-
VgrG2CG474 and hisSlyD-VgrG3CG458 were eluted by imidazole gra-
dient of 20500mM and ethylenediaminetetraacetic acid (EDTA)
was added to the eluted fractions to a ﬁnal concentration of
5mM. The fractions containing the desired protein were collected
and applied to HiTrap Q HP column (GE Healthcare) which was
equilibrated with buffer B (50mM Tris pH8.0). The proteins were
eluted with NaCl gradient of 0 to 1M and further puriﬁed by Hiload
16/60 Superdex200 prep grade column (GE Healthcare) using buffer
C (50mM Tris pH8.0, 100mM NaCl).
The puriﬁcation of VgrG1CG561-his is similar to that of
VgrG1CM467-his but modiﬁed as follows. First, VgrG1CM467-his was
puriﬁed by HisTrap FF column (GE Healthcare) then trypsin was
added on the weight ratio of 100 to 1 (VgrG1CM467-his to trypsin)
and incubated at 25C for 0.51 h in order to digest the N-terminal
region of VgrG1CM467-his. The proteolysis was stopped by the add-
ition of Tosyl-Lys-chloromethyl ketone (TLCK) at a ﬁnal concen-
tration of 0.1mM. VgrG1CG561-his which had been cleaved at the
C-terminus of Arg560 was puriﬁed by HiTrap Q HP (GE
Healthcare) and the fractions containing the desired protein were
mixed and loaded to Hiload 16/60 Superdex75 prep grade column
(GE Healthcare). The SeMet derivative of VgrG1CG561-his was
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puriﬁed in the same way as native protein. All the puriﬁcation was
performed at 4C.
SDSPAGEandN-terminal aminoacid sequencedetermination
SDSPAGE was carried out according to the method of Laemmli
(24) using a minigel and stained with 0.1% Coomassie brilliant blue
G-250 in 10% acetic acid. For the protein sequencing of trypsin-
treated VgrG1CM467-his, proteins were separated by SDSPAGE
and transferred to a polyvinylidene diﬂuoride membrane by electro-
phoresis. The membrane was stained with amido black 10B in 10%
acetic acid and target band was examined. The N-terminal amino
acid sequence was determined by Edman degradation using the
protein sequencer PPSQ-21 (SHIMADZU).
hisSlyD removal from hisSlyD-VgrG3CG458
Hexahistidine-tagged TEV protease harbouring S219V mutation was
prepared from E. coli BL21(DE3)-RIL containing pRK793
(Addgene plasmid 8827) (25). The TEV protease was mixed with
hisSlyD-VgrG3CG458 at a protease to substrate weight ratio of 1:10
and incubated at 30C for 6 h. The sample was taken in every 2 h and
digestion proﬁle was analysed by SDSPAGE after the centrifuga-
tion at 20,000g to separate soluble protein and insoluble protein.
Far-UV CD spectrum
Far-UV CD (circular dichroism) spectrum of VgrG1his and c3393his
was measured at 20C with a J-720 spectropolarimeter (Jasco) and
1mm-path-length quartz cell. Buffer C was used as a control buffer.
The secondary structure was estimated by program CONTINLL
(26) using the wavelength range of 200240 nm.
Analytical ultracentrifugation
Analytical ultracentrifugation was performed by Optima XL-I
(Beckman-Coulter) using a four-hole An60Ti or an eight-hole
An50Ti rotor at 20C. The dialysis buffer or equilibration buffer
for size exclusion chromatography was used as a reference solution.
Sedimentation velocity data of VgrG1his and c3393his were col-
lected with the rotor speed of 129,024g, those of VgrG1CG561-his
were collected at 201,600g and those of hisSlyD-VgrG2CG474 were
collected at 72,576g. Moving boundaries were recorded at the
wave length of 230 nm or 280 nm depending on the concentration
of the protein without time intervals between each scan. The sedi-
mentation coefﬁcient distribution function, c(s), was obtained by
SEDFIT program (27, 28). The distribution of molecular weight,
c(M), was obtained by converting c(s) to c(M) as implemented in
SEDFIT program. The protein partial spec volumes ( ), buffer dens-
ity (r) and buffer viscosity (Z) were calculated by SEDNTERP
program (29).
For the sedimentation equilibrium of VgrG1CG561-his, the samples
with the absorbance at 230 nm of 0.2, 0.3 and 0.5 were centrifuged at
14,480, 20,644 and 58,787g until they reach equilibrium. The
molecular weight was calculated using Origin program with a self-
associating model.
Crystallization and structure determination
For the crystallization, VgrG1CG561-his was dialysed against 10mM
Tris pH8.0 and concentrated by Amicon Ultra 10K (Millipore) to
14mg/ml. The initial crystal of VgrG1CG561-his was obtained in con-
dition B12 of JBScreen Pentaerythritol [45% w/v Pentaerythritol
propoxylate (average M.W. 426), 100mM Tris pH8.5 and
400mM KCl] (Jena Biosciences) by a sitting drop vapour diffusion
method using 96-well MRC 2-drop plate (Swissci). The crystalliza-
tion condition was optimized in 24-well plate (Jena Biosciences) by
hanging drop vapour diffusion method. The biggest crystal was ob-
tained in a drop which consists of 1ml of 5.0mg/ml protein solution
and 1ml well solution containing 48% v/v Pentaerythritol propoxy-
late (average M.W. 426), 100mM CHES pH8.8, 700mM CsCl.
The SeMet derivative did not crystallize under the same condition
as native protein; therefore, we performed crystallization screening
again. The crystal of SeMet derivative was obtained in condition 7 of
Cryo 1 Screen (40% ethanol, 100mM Tris pH8.5, 50mM MgCl2)
(Emerald Biosystem) by a hanging drop vapour diffusion method
using 6.7mg/ml protein and 96-well polystyrene microplate (Greiner
Bio-one). The crystallization condition was subsequently optimized
in 24-well plate (HAMPTON). The best crystal was obtained when
1 ml of 6.7mg/ml protein was mixed with 1 ml of mother liquid
containing 35% v/v ethanol, 100mM Tris pH8.5, 50mM MgCl2
and equilibrated against 1ml of same mother liquid. The crystal
was soaked in cryoprotectant solution containing 40% v/v ethanol,
100mM Tris pH8.5, 50mM MgCl2 for a few seconds and
ﬂash-frozen in liquid nitrogen. Single-wavelength anomalous data
was collected from a single crystal under N2 cryostream (100K) at
BL-1A beamline of Photon Factory at KEK (Tsukuba, Japan) using
a PILATUS 2M-F detector. The crystal belonged to H32, with cell
dimension of a¼ b¼ 49.42 A˚, c¼ 199.14 A˚.
The X-ray diffraction data were indexed using X-ray detector soft-
ware (XDS) (30) and the space group was determined using Pointless
(31). The scaling was performed using SCALA (32). Then phenix.au-
tosol (33) was used for the identiﬁcation of the Se site and calculation
of the phase. The initial model was built in phenix.autosol wizard and
manually modiﬁed using Coot (34). The structure was reﬁned by
Refmac5 (35) and phenix.reﬁne with manual modiﬁcation in Coot.
The ﬁnal model includes the residues Gly561Val569, Ile587Asn633
and the C-terminal hexahistidine tag except for the last histidine resi-
due. The electron density corresponding to the residues
Asp570Ala586 was missing, therefore, the connectivity of the poly-
peptide chain between Val569 and Ile587 was unconﬁdent. The stat-
istics of data collection and reﬁnement are summarized in
Supplementary Table S2.
Bioinformatics
Alignment of amino acid sequences was carried out using ClustalW2
(36) with default parameters. Structure superposition of
VgrG1CG561 to phi92 gp138 was performed with PDBeFold
(Protein Data Bank in Europe) (37). The conservation of the
amino acids was analysed by WebLogo (38) using aligned amino
acid sequences.
Molecular graphics
All the images of protein structure were drawn using MolFeat v4.5
(FiatLux Corporation, Japan).
Results
Expression and purification of VgrG proteins from
E. coli O157 and CFT073 strains
We constructed the over-expression vectors of
VgrG1his, VgrG2his, VgrG3his from E. coli O157 and
c3393his, c1888his, c1883his from E. coli CFT073 (see
Materials and Methods section for details) and exam-
ined their expression proﬁle in E. coli cells
(Supplementary Fig. S1). All of these six VgrG pro-
teins were expressed in high level, but most of them
tend to become insoluble. However, VgrG1his of E. coli
O157 and c3393his from E. coli CFT073 were obtained
in soluble form by 25% and 16% of the total pro-
tein, respectively, which was enough to purify for
further investigations.
VgrG1his and c3393his were puriﬁed by Ni afﬁnity
chromatography by using their hexahistidine tag at
C-terminus, anion exchange chromatography and size
exclusion chromatography at 4C (see Materials and
Methods section for details). Both VgrG1his and
c3393his eluted as a single peak from size exclusion
column and gave nearly a single band in
SDSPAGE (Fig. 1A).
Both VgrG1his and c3393his are trimers in solution
and rich in b-structure
Sedimentation velocity analysis revealed that VgrG1his
and c3393his form a homogeneous oligomer with the
sedimentation coefﬁcients of 8.17S and 9.08S, respect-
ively (Fig. 1B and C). The molecular weight of
VgrG1his was estimated to be 210,000, which is 2.9
times the molar mass of monomer from amino acid
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sequence (72.6 kDa). Similarly, the molecular weight of
c3393his was estimated as 245,000, which is 2.7 times
the molar mass of monomer (92.1 kDa). We, therefore,
concluded that both VgrG1his and c3393his are trimers
in solution.
We also examined the secondary structure of
VgrG1his and c3393his using far-UV CD Spectrum.
The secondary structure estimation indicated that
both VgrG1his and c3393his are rich in b-structure
(b-sheet content of 33% for VgrG1 and 34% for
c3393) (Table I). As it was reported earlier, VgrG
protein is a homologue of the T4 phage gp27gp5 com-
plex without the lysozyme domain of gp5 (3, 14, 39), we
compared their secondary structure contents. The sec-
ondary structure contents of VgrG1his and c3393his were
very similar to that of the crystal structure of gp27gp5
without the lysozyme domain (Table I).
The b-helix domain of VgrG2 and VgrG3 from E. coli
O157 is prone to aggregation
It has been reported that the fusion of SlyD (E. coli
prolyl cis-trans isomerase) could enhance the solubility
of aggregation prone proteins (21, 40). Therefore, we
constructed the over-expression vector of the putative
b-helix domain of VgrG2 (residues 474712) and
VgrG3 (residues 458713) with N-terminal cleavable
hisSlyD (see Materials and Methods section for
details). Both hisSlyD-VgrG2CG474 and hisSlyD-
VgrG3CG458 were expressed in soluble form for more
than 80% and 70% of the total protein, respectively.
We attempted to purify them by Ni afﬁnity chroma-
tography using the N-terminal histidine tag. However,
Fig. 1 Puriﬁcation and characterization of E. coli O157 VgrG1his and E. coli CFT073 c3393his. (A) SDSPAGE of E. coli O157 VgrG1his and
E. coli CFT073 c3393his. Lane M, molecular weight marker; lane 1, E. coli O157 VgrG1his after size exclusion chromatography; lane 2, E. coli
CFT073 c3393his after size exclusion chromatography. The polyacrylamide gel (10%) was stained with Coomassie brilliant blue. The arrows
indicate VgrG1his and c3393his. Faint bands below VgrG1his and c3393his would be partially degraded VgrG1his and c3393his. (B) Sedimentation
velocity analysis of E. coli O157 VgrG1his. The sedimentation velocity data was analysed by SEDFIT. The moving boundaries were measured at
280 nm at 20C. The rotor speed was 40,000 rpm. The molecular weight was obtained by converting c(s) to c(M). (C) Sedimentation velocity
analysis of E. coli CFT073 c3393his. The sedimentation velocity data was analysed by SEDFIT. The measurement condition is same as (B).
(D) Limited proteolysis of VgrG1CM467-his by trypsin. VgrG1CM467-his was digested by trypsin at 25C for 30min and analysed by SDSPAGE
(20%). Lane M, molecular weight marker; lane 1, VgrG1CM467-his before trypsin digestion; lane 2, VgrG1CM467-his after trypsin digestion. The
stable fragment around 7 kDa marker (VgrG1CG561-his) was identiﬁed as the C-terminal region of VgrG1 (residues Gly561Asn633) with
hexahistidine tag by protein sequencing and Ni afﬁnity chromatography. (E) Sedimentation velocity analysis of E. coli O157 VgrG1CG561-his.
Sedimentation velocity data was analysed by SEDFIT. The moving boundaries were measured at 280 nm at 20C. The rotor speed was
50,000 rpm. The molecular weight was determined by the sedimentation equilibrium analysis (data not shown).
Table I. Secondary structure composition of VgrG1his and c3393his.
Protein a-helix (%) b-sheet (%) Turn (%)
VgrG1hisa 17 33 23
c3393hisa 15 34 21
T4 gp27-gp5 without
gp5-lysozyme domainb
11 35 29
aThe secondary structure was estimated by CONTINLL program
using the CD spectrum data at wavelength range of 200—240 nm.
bThe secondary structure composition was calculated from the
crystal structure of T4 gp27gp5 complex (Protein Data Bank
code 1k28).
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495% of hisSlyD-VgrG2CG474 and hisSlyD-
VgrG3CG458 did not bind to the Ni column (data not
shown). In addition, sedimentation velocity analysis of
hisSlyD-VgrG2CG474, which had been further puriﬁed
by anion exchange chromatography and size exclu-
sion chromatography, showed a broad peak in
sedimentation coefﬁcient distribution function, c(s).
Furthermore, in the case of hisSlyD-VgrG3CG458,
removal of hisSlyD resulted in precipitation of
VgrG3CG458 (Supplementary Fig. S2). Hence, we con-
cluded that the b-helix of these VgrG proteins tends to
aggregate.
Limited proteolysis of VgrG1CM467-his by trypsin
Our attempts to crystallize the full-length VgrG1his
protein from E. coli O157 were unsuccessful.
Therefore, we created VgrG1CM467-his which consists
of residues 467633 of VgrG1 (expected b-helix
region) with C-terminal hexahistidine tag.
VgrG1CM467-his was expressed in high level with
70% of the total protein in soluble form. However,
the far-UV CD spectroscopy analysis of puriﬁed
VgrG1CM467-his indicated that it contains a signiﬁcant
amount of disordered region (data not shown). Then
we performed limited proteolysis of VgrG1CM467-his in
order to obtain a stable fragment suitable for crystal-
lization. Trypsin digestion of VgrG1CM467-his gave a
stable fragment in 30min to 1 h at 25C (Fig. 1D).
Protein sequencing and Ni afﬁnity chromatography
revealed that the stable fragment starts with
GTIAGSV (from residue Gly561) and contains the
C-terminal histidine tag. Thus, the fragment was iden-
tiﬁed as the C-terminal 73 residues of VgrG1 with
C-terminal hexahistidine tag (VgrG1CG561-his).
Incompletely digested species were occasionally seen
depending on the batch of puriﬁcation, but they
could be easily separated by size exclusion chromatog-
raphy (data not shown). The sedimentation velocity
analysis indicated that VgrG1CG561-his forms a homo-
geneous molecular species with a sedimentation coefﬁ-
cients of 2.06S (Fig. 1E). Sedimentation equilibrium
analysis gave the molecular weight of 24,400, which
is 2.8 times the molar mass of monomer (8.6 kDa, cal-
culated from amino acid sequence). We thus concluded
that VgrG1CG561-his forms a trimer in the same fashion
as full-length VgrG1his.
Overall crystal structure of VgrG1CG561
The structure of VgrG1CG561 was solved at 1.9 A˚ reso-
lution by using the single-wavelength anomalous dif-
fraction method with the help of a Se-methionine
derivative that contained only one Se atom in the
asymmetric unit of H32 space group (Supplementary
Table S2). VgrG1CG561 forms a three-stranded b-helix
with the width of 24 A˚ and height of 29 A˚ (Fig. 2A and
B). The b-helix of VgrG1CG561 is constituted with
three antiparallel b-sheets each consisting of six
b-strands and one intertwined parallel b-sheet at
C-terminus (Fig. 2A). Each b-strand of antiparallel
b-sheet is constituted of ﬁve or six amino acids and
connected by b-turn.
The electron density was of high quality and the
atomic model for residues 561569 and 587641 and
the C-terminal hexahistidine tag could be easily built.
However, no interpretable density for residues
570586 was observed. Clearly, these residues are dis-
ordered because their orientation is different in differ-
ent molecules comprising the crystal. The 17 residues
missing from the model (570586) raise a question
about the topology of the ﬁrst strand relative to the
rest of the structure—the ﬁrst strand can be part of any
of the three molecules. We assigned the ﬁrst b-strand
to the molecule that forms a b-sheet together with. In
this conﬁguration the missing residues create a large
loop, which might be required for binding effectors to
VgrG, upon which this loop becomes ordered.
The overall structure of VgrG1CG561 is similar to
that of the three-stranded b-helix of T4 phage gp5
and its homologues—the central spike proteins from
different phages (phi92 phage gp138, P2 phage gpV
and phage Mu gp45) (Fig. 2); they all form three-
stranded b-helix which is about 28 A˚ wide (16, 17).
The amino acid sequence of VgrG1CG561 was aligned
with the amino acid sequences of these three-stranded
b-helices by clustalW2 (36) but the identities were all
520%, indicating no primary sequence similarity be-
tween them. Recently, the crystal structure of PA0091
VgrG1a from P. aeruginosa PAO1 was solved (Sycheva
L.V., Shneider M.M., Basler M., Ho B.T., Mekalanos
J.J. and Leiman P.G., in preparation) and its b-helix
is found to mainly consist of intertwined b-sheet.
Thus the overall topology of the b-helix is not con-
served among VgrG proteins. However, the topology
of the last strand of the b-helix in both VgrGs is
similar.
Sharp turns of three-stranded antiparallel b-helix are
stabilized by hydrogen bonds and salt bridge
To examine the nature of antiparallel b-helix of
VgrG1CG561, we ﬁrst focused on the turns at the
corner of the b-helix triangular prism. In those turns,
the side chains of serine and threonine face inwards
where they interact with the main chain of another
polypeptide chain in the trimer (Fig. 3). The side
chain hydroxyl group of Ser597 and Thr614 make
intermolecular hydrogen bonds with the main chain
carbonyl oxygen of Thr602 and that of Ser619 from
another strand, respectively (Fig. 3). In addition, the
side chain hydroxyl group of Thr614 makes an inter-
molecular hydrogen bond with the main chain car-
bonyl oxygen of Lys620 from neighbouring
polypeptide chain via a water molecule which is further
coordinated by the side chain oxygen of Ser613 and
main chain nitrogen of Gly628 (Fig. 3). Although
Val594, which is present at the corner, cannot form
intermolecular hydrogen bond through its side chain,
Glu595 instead makes an intermolecular salt bridge
with the side chain of Lys588 (Fig. 3). In the case of
Val610, the main chain carbonyl oxygen of Val610 and
main chain amide nitrogen of Glu612 and main chain
amide nitrogen of Ser613 make an intermolecular
hydrogen bond with the main chain carbonyl oxygen
of Lys620 via the same water molecule (Fig. 3).
This hydrogen bond network and salt bridge are
likely to be important for stability of the trimer.
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Fig. 3 Stereo diagram of the hydrogen bonds and salt bridge network at the corner of the b-helix. The b-strands are drawn in ribbon model and the
main chain of the b-turn and the side chains which make intermolecular hydrogen bond are represented in stick model. The hydrogen bonds and
salt bridge are shown in dashed line with the residues numbers. To make it easy to see the interactions, only the interface of two polypeptide
strands is depicted.
Fig. 2 Crystal Structure of VgrG1CG561 and comparison with the b-helix domain of central spike proteins of bacteriophage T4, phi92, P2 and Mu.
(A) Structure of VgrG1CG561 represented in ribbon diagram. Each polypeptide chain is drawn in different color. The strategic residues are
labelled with their residue numbers. (B) Topdown view of VgrG1CG561. Triangular shape with 3-fold symmetry is conﬁrmed. (C) The b-helix of
T4 phage gp5 (residues 379575, PDB code 1k28). (D) The b-helix of phi92 phage gp138 (residues 138215, PDB code 3PQI). (E) The b-helix of
P2 phage gpV (residues 98190, PDB code 3QR7). (F) The b-helix of Mu phage gp45 (residues 102176, PDB code 3VTO). One polypeptide
chain is drawn in different colour (CF) to make it easier to see the topology of the b-helix (CE).
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Similar intermolecular hydrogen bonds are observed
in gp138 of phi92 phage (PDB code 3PQH), in which
the hydrogen bonds are made between asparagine or
aspartic acid and the main chain oxygen or nitrogen of
neighbouring polypeptide chain (17). Furthermore, in
the antiparallel b-sheet region of VgrG1a from P. aer-
uginosa PAO1, the corner is occupied by the side chain
of cysteine and serine, which also creates an intermo-
lecular hydrogen bond with the main chain oxygen of
neighbouring polypeptide chain. Thus, the hydrogen
bond network and salt bridges are conserved in anti-
parallel b-helix.
The three-stranded antiparallel b-helix is narrower
than intertwined b-helix
The inside of the VgrG1CG561 b-helix is ﬁlled with the
side chain of hydrophobic residues such as isoleucine
and leucine that form its hydrophobic core. The hydro-
phobic core is also found in other triple-stranded
b-helices such as T4 gp5, phi92 gp138, P2 gpV and
VgrG1a of P. aeruginosa PAO1 regardless of their dif-
ferent topology (16, 17, Sycheva L.V., Shneider M.M.,
Basler M., Ho B.T., Mekalanos J.J. and Leiman P.G.,
in preparation). To further examine the structural fea-
ture of antiparallel b-helix, we measured the inter-resi-
due distance between Cb of Ile and Leu which is
located at the center of b-strand. The average of
inter-residual Cb distances of Ile480, Ile496, Ile512 of
T4 gp5 and Leu514, Leu546, Ile562 of P. aeruginosa
PAO1 VgrG1a, which are located in intertwined b-
helix, was 10.6 0.7 A˚. On the other hand, the average
of inter-residual Cb distances of Leu570, Ile587 of P.
aeruginosa PAO1 VgrG1a and Leu592, Ile599, Leu608,
Leu616, Leu625 of VgrG1CG561, which are located in
antiparallel b-helix, was 8.5 0.8 A˚ which is about 2 A˚
shorter than that of intertwined b-helix (Fig. 4).
Discussion
It is highly intriguing from the viewpoint of function
and evolution that bacterial T6SS have a number of
structurally similar proteins to contractile tails of bac-
teriophage (3, 14). VgrG protein in the T6SS shares
three homologous domains with the gp27gp5 cell
puncturing device of T4 phage, namely, the gp27
domain, the OB fold domain and three-stranded
b-helix (3, 14). In this study, we examined the over-
expression proﬁle of six VgrG proteins from E. coli
O157 and CFT073 strains and found that most of
them are insoluble indicating either completely incor-
rect folding or aggregation immediately after partially
correct folding. It was unexpected, because the
gp27gp5 complex, which is a T4 phage orthologue
of VgrG, is a stable and soluble protein complex (16).
We hypothesized that folding of VgrG proteins can be
facilitated by generic cellular chaperones—DnaK,
DnaJ, GrpE, GroEL, GroES—and performed co-
expression of VgrGs with these proteins. However,
solubility of VgrG proteins was unaffected (data not
shown). It is clear, however, that folding of VgrG pro-
teins requires specialized molecular chaperones or
partner molecules. A good candidate to perform this
function would be proline-alanine-alanine-arginine
(PAAR)-repeat motif proteins that have been recently
shown to bind to the C-terminal blunt end of the
b-helix of T4 gp5VgrG chimeric protein (41). The
hypothesized function of these PAAR motif proteins
is to form a nucleation point to facilitate the folding of
the topologically complex b-helical domain of VgrG
proteins. Interestingly, inactivation of all PAAR
motif proteins led to functional defect of T6SS in
V. cholerae and Acitenobacter baylyi (41). PAAR
motifs are often a part of an RHS protein-encoding
gene, which is frequently found downstream of a
vgrG gene (41) and indeed, every T6SS locus of
E. coli O157 contains an RHS gene after a vgrG
gene. VgrG and RHS proteins are extremely diverse
and not every bacterium with a functional T6SS con-
tains an RHS protein, but at least in E. coli O157 RHS
proteins may function as molecular chaperones of
VgrGs.
The crystal structure of the N-terminal region of
E. coli CFT073 c3393 has been already reported and
was shown that it forms a trimer that is structurally
similar to T4 gp27gp5 complex, but the lysozyme
domain is absent (14). In the present study, we
showed that full-length VgrG1his of E. coli O157 and
c3393his of E. coli CFT073 are also trimer in solution
and contain similar secondary structure as that of the
T4 gp27gp5 complex without the lysozyme domain,
which supports the idea that VgrG proteins contain
three-stranded b-helix as the T4 gp5 does (3). We
determined the crystal structure of C-terminal 73 resi-
dues of VgrG1 (VgrG1CG561) by X-ray crystallog-
raphy and demonstrated that they indeed form a
three-stranded b-helix. The overall structure of
VgrG1CG561 was similar to the three-stranded b-helix
domain of T4 gp5, P2 gpV and phi92 gp138. Out of
these three proteins, the b-helix of phi92 gp138 was
most similar to VgrG1CG561 in topology of the poly-
peptide chain. The rmsd (root mean square deviation)
of residues 587633 region of VgrG1CG561 and the
corresponding residues 155202 of phi92 gp138 was
1.22 A˚ over 46 amino acids on Ca atoms, which indi-
cated that not only the topology but also the three-
dimensional structure is similar. The VgrG1CG561
Fig. 4 The core of antiparallel b-helix is narrower than intertwined
b-helix. (A) The main chain of the antiparallel b-helix of VgrG1
(residues 604611) and the side chain of Leu608 are drawn in stick
model. The intermolecular Cb distance of Leu608 is displayed.
(B) The main chain of the intertwined b-helix of T4 gp5 (residues
476483) and the side chain of Ile480 is drawn in the stick model in
the same scale as (A). The intermolecular Cb distance of Ile480 is
displayed. Note that parallel b-helix is narrower than intertwined
b-helix.
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shows further similarity with phi92 gp138 in the stabil-
ization mechanism of trimer; both of VgrG1CG561 and
phi92 gp138 are stabilized by the hydrophobic inter-
action and the intermolecular hydrogen bonds at the
corner of b-helix. Escherichia coli is one of the hosts of
phi92 phage. Therefore, it is possible that VgrG1CG561
is evolutionarily related with gp138 of phi92 phage.
We found that VgrG1CG561 contains a long ﬂexible
loop between Asp570 and Ala586, but it was not ex-
pected before the structure was determined, because
the central spike proteins of bacteriophages with
known structure do not have a loop insertion within
the three-stranded b-helix. However, a long loop inser-
tion before three-stranded b-helix was observed in T4
gp5 (16) and the loop after three-stranded b-helix was
recently found in VgrG1a of P. aeruginosa (Sycheva
L.V., Shneider M.M., Basler M., Ho B.T.,
Mekalanos J.J. and Leiman P.G., submitted for pub-
lication, in preparation). In the case of T4 gp5, a lyso-
zyme domain is inserted before b-helix and it is
connected to b-helix by a 51-residues loop. On the
other hand, VgrG1a of P. aeruginosa contains a loop
after b-helix though no enzymatic domain is present. It
is, however, reported that VgrG proteins occasionally
carry an enzyme domain, called effector domain, at the
C-terminus (e.g. actin crosslinking domain of V. cho-
lerae VgrG1 and lysozyme-like chitosanase domain of
V. cholerae VgrG3) (3, 8) and those domains are pre-
dicted to be ﬂanked by a long loop (42). Taking these
facts into consideration, it is possible that a certain
VgrG protein might carry an effector domain within
b-helix though such a VgrG has not been reported yet.
The three-stranded b-helices can be classiﬁed into
two categories, namely, antiparallel b-helix and inter-
twined b-helix. However, it is not obvious to decide
which sequence dictates which conformation. Until
now, a number of the structures of b-helices have
been determined (16, 17) which can be categorized as
two topologically different types. In order to formulate
a consensus sequence for either antiparallel b-helix or
intertwined b-helix, we performed structure-based se-
quence alignment of each category and examined the
conservation of the amino acids along each sequence
(Fig. 5A and B).
The sequence alignment of the antiparallel b-helix
region of VgrG1CG561, VgrG1a of P. aeruginosa
PAO1 and phi92 gp138 revealed three types of amino
acid preferences. The ﬁrst type was observed in the
inward pointing residues that form the core of the
b-helix (Fig. 5A, closed circle). Hydrophobic residues
such as leucine, isoleucine and valine are preferred and
form a hydrophobic core to stabilize the trimer as we
described in the ‘Results’ section. The second type was
seen in the inward pointing residues whose side chain
ﬁlls the inside of the corner (Fig. 5A, open circle).
Small polar residues such as asparagine, serine and
threonine are preferred at the positions and they
form intermolecular hydrogen bonds. The last type
was seen in the second b-turn (Fig. 5A, position 16
and 17). The preference here is proline, asparagine
and aspartic acid, which are typical b-turn forming
residues.
On the other hand, the sequence alignment of the
intertwined b-helix region of T4 gp5 and that of
VgrG1a of P. aeruginosa PAO1 indicated the prefer-
ence of asparagine, aspartic acid at the ﬁrst amino acid
of the b-strand, valine, isoleucine at the last amino acid
of the b-strand and glycine at the kink between each
b-strand (Fig. 5B). Some of these preferences of the
amino acids have been already reported and explained
based on three dimensional structures (16, 17).
We next, examined the sterically disallowed amino
acids, i.e. unacceptable amino acids due to the pre-
dicted steric hindrance, at inward pointing residues in
order to make the prediction more accurate. As shown
in Fig. 4, inside of the antiparallel b-helix is narrower
as compared with that of the intertwined b-helix.
Therefore, amino acids with bulky or long side chain,
i.e. tryptophan, arginine and lysine, are not acceptable
(Fig. 5A). Other bulky amino acids such as phenyl
alanine and tyrosine are acceptable, but the inward
pointing neighbor residue has to be small such as
valine, alanine or glycine. On the other hand, the
inside of intertwined b-helix is wider than that of the
Fig. 5 Consensus sequence and structurally forbidden amino acids of antiparallel and intertwined b-helix. (A) The antiparallel b-helix regions of
VgrG1CG561, VgrG1a of P. aeruginosa PAO1 and phi92 gp138 were aligned manually and conservation of the amino acid was visualized by
WebLogo (38) with frequency plot option. The arrow indicates the b-strands. The closed circle indicates the inward pointing residues and open
circle indicates the amino acid whose side chain occupies the inside of the corner. Asterisk indicates the occasional insertion in b-turn. Sterically
forbidden amino acids were identiﬁed by manually introducing mutation using Coot. (B) The intertwined b-helix regions of T4 gp5 and VgrG1a
of P. aeruginosa PAO1 were aligned manually and visualized by WebLogo with frequency plot option. Same symbols are used as (A). Sterically
disallowed amino acids were identiﬁed in the same way as (A).
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antiparallel b-helix so that the amino acids with bulky
or long side chain are acceptable. In fact, tryptophan,
arginine and lysine are seen in the inside of T4 gp5
b-helix (16). In both antiparallel and intertwined
b-helix, however, the corner of the b-helix cannot ac-
commodate bulky side chains. The side chains are
ﬂanked by the backbone and the side chain of the
neighbouring b-sheet, thus bulky amino acids such as
phenylalanine and tyrosine are not allowed in addition
to tryptophan, arginine and lysine (Fig. 5).
We applied this consensus sequence with sterically
forbidden amino acids (Fig. 5) to VgrG3 of E. coli
O157 and c3393 of E. coli CFT073 and predicted
that these VgrG proteins would form intertwined
b-helix and mixture of intertwined and antiparallel
b-helix, respectively (Supplementary Fig. S3). We are
going to solve their atomic structure by X-ray crystal-
lography and conﬁrm their predicted topology of the
b-helix.
Supplementary Data
Supplementary Data are available at JB Online.
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